Prucalopride in Postoperative Ileus
Launched by UNIVERSITY OF AUCKLAND, NEW ZEALAND · Oct 25, 2016
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients from Auckland District Health Board catchment
- • Age 18 or older
- • Elective and subacute surgery
- • Right hemicolectomy, left hemicolectomy, sigmoid colectomy, anterior resection, Hartmann's procedure, subtotal colectomy
- • Operation with or without the formation of a colostomy
- • Indication for operation: colon cancer, diverticular disease, gynaecological
- • Able to understand risks and benefits of the study
- • Able to give informed consent
- Exclusion Criteria:
- • ASA 4 or greater
- • Allergy to any serotonin medication
- • Active inflammatory bowel disease
- • Planned formation of an ileostomy during surgery
- • Moderate to severe renal impairment (Creatinine clearance\<50mL/min/1.73m2)
- • Severe hepatic impairment (Child-Pugh C)
- • Pregnancy
- • Pre-existing gut dysmotility disorder including endocrine, metabolic or neurological cause
- • Pre-operative malnutrition requiring parenteral nutrition
- • Inability to give consent or participate in post-operative assessments due to dementia, cognitive impairment, language difficulties, delirium
About University Of Auckland, New Zealand
The University of Auckland, located in New Zealand, is a leading research institution committed to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and pharmacology to conduct rigorous studies that address pressing health challenges. The institution is dedicated to ethical research practices and aims to translate findings into meaningful clinical applications, ultimately enhancing patient care and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Auckland, , New Zealand
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials